Lactobacilli are part of normal gastrointestinal and genitourinary flora but are an uncommon cause of bacteremia. We reviewed the cases of 45 patients with clinically significant lactobacillus bacteremia occurring over 15 years. Underlying conditions were common, including cancer (40%), recent surgery (38%), and diabetes mellitus (27%). Twenty-two patients were in the intensive care unit at the time of onset of lactobacillus bacteremia. Eleven of the 45 patients were receiving immunosuppressive therapy, 11 were receiving total parenteral nutrition, and 23 had received antibiotics without activity against Lactobacillus prior to the occurrence of bacteremia. Bacteremia was polymicrobial in 27 patients and developed during hospitalization in 39. Thirty-one patients died, but only one death was attributable to lactobacillus bacteremia. Lactobacilli are relatively avirulent pathogens that produce bacteremia in patients with serious underlying illnesses, many of whom have received prior antibiotic therapy that may select out for the organism. While rarely fatal in itself, lactobacillus bacteremia identifies patients with serious and rapidly fatal illness.
The lactobacilli are anaerobic or facultatively anaerobic who had lactobacilli isolated from one or more blood cultures gram-positive rods that are part of the normal flora of the were identified. Six patients were excluded because the organgastrointestinal and genitourinary tracts [1, 2] . Lactobacillus is ism was considered a contaminant. These patients received no rarely a human pathogen but has been reported to cause dental therapy and did well. caries [3] , infective endocarditis [3 -12] , urinary tract infections Microbiological techniques. The blood culture methods over [13, 14] , chorioamnionitis [15] , endometritis [3] , meningitis this 15-year study period varied. The BACTEC 460 system [8] , intraabdominal abscess [3] , liver abscess [16] , splenic ab-(Becton Dickinson, Sparks, MD) was used between 1979 and scess [17] , and bacteremia [3, 9, 18] .
1983, when it was replaced by the BACTEC 660 system, each Few studies have examined the epidemiology and long-term involving the inoculation of 3 -5 mL of blood into aerobic and outcome of lactobacillus bloodstream infection (table 1) . The anaerobic bottles. In 1986 this system was replaced by the 10-largest review, by Antony et al. [18] , described only 12 patients mL Isolator system (Wampole Laboratories, Cranbury, NJ) and and discussed the prior literature. Other recent studies have a bottle containing tryptic soy broth (Difco Laboratories, Dereported lactobacillus bacteremia in small series of liver transtroit). Beginning in 1992 the tryptic soy broth bottle was replant recipients and patients with AIDS [16, 19] . We recently placed successively by the ESP Aerobic 80A bottle (Difco encountered several patients with clinically significant lactobaLaboratories) and the BACTEC Plus Aerobic/F bottle (Becton cillus bacteremia at the Cleveland Clinic Foundation (CleveDickinson). land, OH), which prompted us to retrospectively review our Lactobacilli were identified presumptively by standard methinstitutional experience with regard to the clinical presentation, ods, including a characteristic gram-stain morphology after epidemiology, and outcome of this infection.
growth on agar media incubated aerobically and anaerobically, a negative catalase reaction, and the absence of hydrogen sulfide formation in a triple sugar agar slant. Additional confirmaMaterials and Methods tory tests for isolates lacking characteristic morphology or presumptive identification test reactions included nitrate reduction, Case ascertainment. The blood culture records of the microindole production, and carbohydrate fermentation reactions. biology laboratory at the Cleveland Clinic Foundation from Susceptibility testing of Lactobacillus isolates was performed between June 1979 and December 1994 were reviewed to idenby the microdilution method from 1979 to 1994. MBCs were tify patients with lactobacillus bacteremia. A total of 51 patients not determined.
Case definitions and data analysis. Cases were classified as definite, probable, or possible. A definite case of lactobacillus nancy, and 17 (38%) had recently undergone surgery. Most surgeries were abdominal procedures; three patients had recently undergone endoscopy. Twenty-seven percent of patients and with signs and symptoms of infection referable to a site had diabetes mellitus, 22% were receiving corticosteroids, and likely to yield the organism. Leukocytosis was defined as a 14% were receiving other immunosuppressive therapy. Eleven value of ú11,000 WBCs/mL. patients (24%) were receiving hyperalimentation, three (7%) The medical records of 45 patients were reviewed, and data had valvular heart disease, and two (4%) had ulcerative colitis. were abstracted concerning demographic variables, clinical Two patients had previously undergone lung transplantation, presentation, presence of underlying diseases, source of bacterwhile one had received a cardiac transplant. In all three transemia, microbiological findings, therapy, and outcome. Data plant recipients, lactobacillus bacteremia occurred postoperaanalysis was performed with use of Epi Info, version 6 (Centers tively within the first 2 weeks following transplantation. for Disease Control and Prevention, Atlanta).
Twenty-three patients (51%) received antibiotics without activity against lactobacilli before the onset of bacteremia, including nine who received vancomycin.
Results
Of the six patients who presented to the hospital with lactobacillemia, all had polymicrobial bacteremia, none were prePatient characteristics. Forty-five patients with lactobacillus bacteremia were identified during the 15-year study period, and viously healthy, and all had significant underlying medical illnesses, including cancer of the genitourinary tract in three (table  their characteristics are summarized in table 2 . Lactobacilli were isolated in Ç0.085% of blood cultures processed by the 2; cases 31, 33 -36, and 38). The portal of entry was not identified in 76% of patients. microbiology laboratory of the Cleveland Clinic Foundation during the study period. The incidence of cases over the study Documented portals of entry included intraabdominal abscesses (6), endocarditis (2), other endovascular sources (2), and factiperiod was constant (mean, 3 cases/year). There were 23 males and 22 females. The average age of patients was 61 years tious (1) . Clinical features. Signs and symptoms at the time of lactoba-(range, 27 -85 years).
All patients were inpatients at the time of diagnosis of cillus bacteremia included fever (69%), leukocytosis (22%), and rigors (23%). One patient was hypothermic at presentation. lactobacillus bacteremia. In six patients (13%), lactobacillus bacteremia was diagnosed within 48 hours of admission, Leukopenia was noted in five patients, with values ranging from 2.2 to 4.43 1 10 3 /mL. One patient had a WBC count of whereas 39 patients developed bacteremia ú48 hours after admission; these latter cases were considered nosocomial.
61,000/mL as a manifestation of his primary disease. Therapy. Antimicrobial therapy for lactobacillus bacteremia The duration of bacteremia ranged from 1 day to 14 days (mean, 1.5 days). Forty patients had bacteremia for only 1 was not standardized. The antibiotics most frequently used included penicillin (25) , clindamycin (26), and vancomycin day. There were 23 definite cases, 16 probable cases, and 6 possible cases (table 2) . (10) . Four patients received combination therapy with a penicillin and an aminoglycoside, although the aminoglycoside was Microbiological data. The total number of blood cultures that yielded lactobacilli ranged from one to 13 per patient.
withdrawn within 5 days for all patients. The duration of therapy ranged from 1 to 45 days (mean, 11 days). Twenty-eight patients (62%) had a single positive blood culture. The patient with 13 positive blood cultures had an endoFor the two patients with endocarditis (cases 12 and 19), monotherapy was employed. One patient underwent valve revascular source of infection. In 27 patients (60%), bacteremia / 9c3f$$no64
10-23-97 10:58:29 cidal UC: CID NOTE. ABT Å antibiotic therapy; AML Å acute myelocytic leukemia; Amp Å ampicillin; AVR Å aortic valve replacement; CA Å clavulanic acid; CABG Å coronary artery bypass graft; CAD Å coronary artery disease; cfox Å cefoxitin; CHF Å congestive heart failure; Chl Å chloramphenicol; CLL Å chronic lymphocytic leukemia; Cm Å clindamycin; Cman Å cefamandole; Cpfx Å ciprofloxacin; CRF Å chronic renal failure; Ctax Å cefotaxime; CVA Å cerebrovascular accident; Czox Å ceftizoxime; DVT Å deep-vein thrombosis; Em Å erythromycin; GI Å gastrointestinal; Gm Å gentamicin; IHSS Å idiopathic hypertrophic subaortic stenosis; Imi Å imipenem; Naf Å nafcillin; NHL Å non-Hodgkin's lymphoma; P/A/C Å prednisone/azathioprine/cyclosporine; Pen Å penicillin; Pip Å piperacillin; SLE Å systemic lupus erythematosus; Tic Å ticarcillin; Tm Å tobramycin; TPN Å total parenteral nutrition; Vm Å vancomycin. * Polymicrobial bacteremia.
placement and postoperatively received vancomycin for 5 days, only one death was directly attributable to lactobacillemia, and this patient had polymicrobial bacteremia at the time (case 11). followed by penicillin for 23 days. The other patient was treated with penicillin G (20 million units/d) for 45 days. Both patients At the 1-year follow-up, 69% of patients had died. Ten late deaths occurred after the hospitalization in which lactobacillus were cured. Three patients received iv antibiotics at home for 5 -34 days. Forty-two patients (98%) improved clinically, and bacteremia occurred. In all cases, deaths were attributed to underlying diseases rather than to lactobacillus bacteremia. their bacteremia cleared with therapy. Three patients did not have follow-up blood cultures performed.
Comparison of different subgroups. There were no statistically significant differences in the clinical setting, underlying Outcome. Twenty-two patients (44%) died during the hospitalization in which lactobacillus bacteremia occurred; however, diseases, sources of bacteremia, therapy, or outcome in the / 9c3f$$no64 10-23-97 10:58:29 cidal UC: CID cillemia during hospitalization for other indications. Our patients were elderly (mean age, 61 years) and had significant underlying comorbidities, including cancer (40%), recent surgery (38%), and diabetes mellitus (27%). Forty-eight percent group of 27 patients who had polymicrobial bacteremia vs. the 15 patients with monomicrobial lactobacillemia. Patients with were hospitalized in the intensive care unit setting, and 51% had received systemic antibiotic therapy with no activity against lactobacillemia diagnosed within 48 hours of admission were more likely to have polymicrobial bacteremia than were palactobacilli before the onset of lactobacillus bacteremia. The mean length of hospital stay was 15 days for those tients with nosocomial lactobacillemia (6/6 vs. 21/39; P Å .04). The mean length of stay in the hospital was 15 days for those who were bacteremic at admission and 39 days for those who developed bacteremia during their hospitalization, which unwho were bacteremic on admission, vs. 39 days for those who developed bacteremia later in their hospital course. There was derscores the severity of illness of our cohort. Earlier reports have described lactobacillus infection in less chronically ill no difference in the frequency of an identifiable portal of entry between the six patients who were bacteremic on admission populations, such as those with dental caries [3] , postpartum endometritis, and endocarditis in the setting of underlying valand the 39 with lactobacillus bacteremia of later onset (P Å .5). Mortality was comparable in the two groups (P Å .3). vular heart disease, injection drug use, or recent dental work [3, 4] . More recent reports have identified lactobacillus bacteremia as a complication of liver transplantation [16] , AIDS Discussion
[19], metastatic choriocarcinoma [20] , and prolonged marrow aplasia [21] . Our findings extend these observations and emWe have reviewed 45 cases of lactobacillus bacteremia encountered at our institution over a period of 15 years. To our phasize that lactobacillemia is an occasional complication in chronically ill and debilitated patients with a history of recent knowledge, this represents the largest single institutional experience analyzed in the literature with regard to the epidemiology abdominal surgery, cancer, diabetes mellitus, or solid organ transplantation and in those receiving chronic immunosuppresand clinical outcome of this entity. In our institution, lactobacillemia has been an uncommon infection with a stable incidence sive therapy. Third, our series describes the occurrence of lactobacillus over the past one and a half decades. Our findings confirm the observations of others that lactobacilli exhibit a low level of bacteremia in clinical settings not previously reported. We encountered two lung transplant recipients with lactobacillus virulence and that lactobacillus bacteremia is rarely fatal in itself but serves as an important marker of serious or fatal bloodstream infection. Although the occurrence of lactobacillemia following hepatic [16] and heart [22] transplantation has underlying disease [16] . Bacteremia cleared in 98% of our patients, and only one death was directly attributable to lactobeen described, to our knowledge it has not been reported to occur in lung transplant recipients. In one case, bacteremia bacillemia. However, 44% of patients died during the hospitalization in which bacteremia occurred, and mortality 1 year resulted from a bronchial anastomotic leak, while in the second case no source was found. Bacteremia in the heart transplant following the bacteremic episode for the entire group was 69%.
Several points concerning our series merit emphasis. First, recipient was transient and of unclear source. Fourth, it is important to emphasize that not all positive lactobacillus bacteremia was polymicrobial in 60% of cases, including all cases diagnosed within 48 hours of initial hospitalblood cultures for lactobacilli are clinically significant, and lactobacilli are occasional contaminants. Of 51 patients with ization. Concomitant bloodstream isolates included streptococci, Candida species, and enteric gram-negative bacilli. The positive blood cultures initially identified in our review, six were excluded because they failed to meet our case definitions association of lactobacilli with polymicrobial bacteremia has been noted in prior reports but has not been emphasized. In and the organisms were deemed contaminants. When interpreting the significance of a positive blood culture for lactobathe study of Bayer et al. [3] , 2 of 3 patients with endocarditis / 9c3f$$no64
10-23-97 10:58:29 cidal UC: CID cilli, careful analysis of the patient's signs and symptoms is therapy was 11 days (range, 1 -45 days). Most patients were treated with either penicillin or clindamycin. Six patients reessential.
Prior studies have identified the oropharynx [2], gastrointesceived parenteral vancomycin, all of whom did well, and their lactobacillemia cleared. It is conceivable that in some patients, tinal tract [12, 23] , and female reproductive tract [14] as the most common portals of entry for lactobacillus bacteremia. We especially those six with only a single positive blood culture for lactobacilli, bacteremia may have been transient and would failed to identify a definitive portal of entry in 76% of our patients, in part owing to the retrospective nature of our study.
have resolved without any specific therapy. This issue is difficult to resolve in a retrospective study, however. However, the polymicrobial nature of lactobacillus bacteremia in 60% of our cohort, together with the other organisms inLactobacillus infection of endovascular surfaces merits emphasis, although it is uncommon. Since 1938, 42 cases of lactovolved, suggests that these sites were the sources of bacteremia in many of our patients.
bacillus endocarditis have been reported in the Englishlanguage literature [11, 12] . We add two more (cases 12 and This inference is supported by the fact that 38% of patients had recently undergone an abdominal surgical or endoscopic 19). Prior reports have emphasized several important points, including the propensity for embolization (which occurred in procedure. Transient lactobacillemia following upper endoscopy has been well documented [23] . Although postpartum one of our patients), the substantial risk of relapse following medical therapy, and the occasional need for valve-replacement endometritis is a recognized source of lactobacillus bacteremia, we encountered no such cases in our series (our hospital had surgery to achieve cure. Although no prospective comparative treatment trials have no obstetrical service during the study period). Similar to the experience of others [18], we had no cases of line-related lactobeen conducted, combination therapy with high-dose penicillin or ampicillin together with an aminoglycoside has been advobacillus bacteremia.
In addition to an obvious portal of entry, in other studies cated [3, 11] . Neither of our cases received combination therapy; one required valve replacement, and both did well. We prior vancomycin use, selective digestive decontamination, and the presence of a Roux-en-Y choledochojejunostomy in the agree, however, that combination therapy is probably indicated in patients with lactobacillus infective endocarditis. We ensetting of liver transplantation have been identified as risk factors for the development of lactobacillus bacteremia [16, 19] .
countered two other cases of endovascular infection, one arising from an infected vascular graft and the other involving a Twenty percent of our patients had received vancomycin prior to the onset of lactobacillus bacteremia, and 51% had received subclavian thrombus at a site of a prior central line (cases 23 and 16). Both patients ultimately died, but in neither case was parenteral antibiotic therapy likely to select out lactobacilli. We believe that these were important risk factors in our population.
death directly attributable to lactobacillus bacteremia. In summary, in our experience lactobacillus bacteremia is None of our patients received selective digestive decontamination and none had a Roux-en-Y. While we did not perform an uncommon infection, is frequently polymicrobial, and is rarely in itself fatal. Lactobacilli are relatively avirulent pathoa case-control study to test the significance of the following risk factors, we were impressed by the high incidence of recent gens. In our experience, when lactobacillus bacteremia occurs, it serves as a marker of serious underlying illness and poor abdominal surgery, total parenteral nutrition use, malignancy, and chronic immunosuppression in our population. Whether long-term prognosis for hospitalized patients. these are important individual risk factors for the development of lactobacillus bacteremia or simply identify a population of
